TW202120078A - 促進軟骨再生用組成物 - Google Patents

促進軟骨再生用組成物 Download PDF

Info

Publication number
TW202120078A
TW202120078A TW109125272A TW109125272A TW202120078A TW 202120078 A TW202120078 A TW 202120078A TW 109125272 A TW109125272 A TW 109125272A TW 109125272 A TW109125272 A TW 109125272A TW 202120078 A TW202120078 A TW 202120078A
Authority
TW
Taiwan
Prior art keywords
composition
cartilage regeneration
hydroxyl group
general formula
promoting
Prior art date
Application number
TW109125272A
Other languages
English (en)
Chinese (zh)
Inventor
大祐多
船木亜由太
Original Assignee
日商三得利控股股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商三得利控股股份有限公司 filed Critical 日商三得利控股股份有限公司
Publication of TW202120078A publication Critical patent/TW202120078A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
TW109125272A 2019-08-02 2020-07-27 促進軟骨再生用組成物 TW202120078A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019143144 2019-08-02
JP2019-143144 2019-08-02

Publications (1)

Publication Number Publication Date
TW202120078A true TW202120078A (zh) 2021-06-01

Family

ID=74503458

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109125272A TW202120078A (zh) 2019-08-02 2020-07-27 促進軟骨再生用組成物

Country Status (9)

Country Link
EP (1) EP4008401A4 (https=)
JP (1) JP7457713B2 (https=)
KR (1) KR20220042403A (https=)
CN (1) CN114206330A (https=)
AU (1) AU2020324628A1 (https=)
CA (1) CA3147400A1 (https=)
PH (1) PH12022550260A1 (https=)
TW (1) TW202120078A (https=)
WO (1) WO2021024801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457353B2 (ja) * 2020-04-28 2024-03-28 学校法人北陸大学 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
US20240390407A1 (en) * 2021-09-17 2024-11-28 Hokuriku University Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter
WO2025031857A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising carboxamides
CN117736980B (zh) * 2024-02-20 2024-05-10 广东先康达生物科技有限公司 脂肪间充质干细胞转化成软骨细胞的诱导分化培养基及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JP4592249B2 (ja) * 2001-11-30 2010-12-01 江崎グリコ株式会社 リウマチの症状改善用飲食品および医薬
KR100437274B1 (ko) * 2003-10-15 2004-06-24 주식회사 케이엠에스아이 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis
RU2521227C1 (ru) * 2013-03-28 2014-06-27 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита, остеопороза и остеоартроза суставов
CA2913621A1 (en) * 2013-05-29 2014-12-04 Nestec S.A. Compositions for use in cartilage breakdown
EP3563855A1 (en) * 2013-10-14 2019-11-06 Société des Produits Nestlé S.A. Treatment or prevention of synovitis using anti-inflammatory phytonutrients
JP6742575B2 (ja) 2015-07-02 2020-08-19 株式会社東洋新薬 関節機能改善組成物
KR101794503B1 (ko) * 2016-03-24 2017-11-08 주식회사 티제이씨라이프 강글리오사이드 ｇｍ３를 함유하는 연골세포 분화 유도용 조성물 및 이의 이용
CN108938618B (zh) * 2018-06-25 2022-04-22 中国科学院动物研究所 延缓人间充质干细胞衰老的化合物及其应用

Also Published As

Publication number Publication date
PH12022550260A1 (en) 2022-11-21
CN114206330A (zh) 2022-03-18
CA3147400A1 (en) 2021-02-11
WO2021024801A1 (ja) 2021-02-11
AU2020324628A1 (en) 2022-03-10
EP4008401A1 (en) 2022-06-08
KR20220042403A (ko) 2022-04-05
JPWO2021024801A1 (https=) 2021-02-11
JP7457713B2 (ja) 2024-03-28
EP4008401A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
TW202120078A (zh) 促進軟骨再生用組成物
US11191814B2 (en) Pet food formulation with cannabinoids
DK2628484T3 (en) Trombocytrige plasma compositions
EP1937232B1 (en) Nutraceutical composition for the treatment of muscle wasting
KR100946822B1 (ko) 칼슘 함유 조직 강화제 및 그 용도
KR20140075844A (ko) 알긴산을 포함하는 골관절염 예방 또는 치료용 조성물
US20230346894A1 (en) Formulation with cannabinoids
US20090181923A1 (en) Method of increasing weight gain and reducing diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics
CN105558435A (zh) 一种用于防治鲢鱼出血病的饲料添加剂
CN101829129B (zh) 兽用复方硫酸庆大霉素注射液及其制备方法
HK40068648A (zh) 软骨再生促进用组合物
KR20070051854A (ko) 칼슘 결핍증 예방 및/또는 치료용 제제
Hamady INFLUENCE OF DIETARY NARINGIN SUPPLEMENTATION ON PRODUCTIVE PERFORMANCE AND SOME BLOOD PARAMETERS OF BROILER.
JP7626713B2 (ja) コンドロイチン硫酸合成促進用組成物
HK40079603B (zh) 硫酸软骨素合成促进用组合物
US20090163579A1 (en) Novel use of nutraceutical compositions
Jacobs et al. Alterations in serum levels, anti-tumor activity and toxicity of methotrexate in rats after a short period of nutritional depletion
Lacy et al. Food intake response of genetically selected high and low-weight line cockerels to plasma infusions from fasted fowl
US20170231934A1 (en) Compositions including anthocyanin or anthocyanidin metabolites for the prevention or treatment of articular cartilage-associated conditions
WO2018204621A1 (en) Compositions including protocatechuic acid for the prevention or treatment of osteoarthritis
Falchetti et al. Osteodietology
JPH01501707A (ja) 表皮成長因子の使用におけるまたは関する改良
US20220023253A1 (en) Cannabinoid Compositions and Methods for Treating Joint Pain and Inflammation
KR20240133426A (ko) 호데닌을 포함하는 골 재생용 조성물 및 이의 용도
Wardlaw Joint nutraceuticals: when and where they can improve joint health.